We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+6.94%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$54.2B
AUM Growth
+$30.1B
Cap. Flow
+$28.6B
Cap. Flow %
52.81%
Top 10 Hldgs %
15.56%
Holding
4,600
New
1,635
Increased
1,281
Reduced
635
Closed
782

Sector Composition

Rank Sector Weight
1 Technology 17.77%
2 Healthcare 17.47%
3 Financials 15.58%
4 Consumer Discretionary 12.3%
5 Communication Services 8.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ETON icon
2901
Eton Pharmaceutcials
ETON
$1.28B
$395K ﹤0.01%
+92,092
New +$441K
JACK icon
2902
Jack in the Box
JACK
$308M
$395K ﹤0.01%
+4,510
New +$419K
BIG
2903
DELISTED
Big Lots, Inc.
BIG
$395K ﹤0.01%
+8,772
New +$399K
AGCB
2904
DELISTED
Altimeter Growth Corp 2
AGCB
$394K ﹤0.01%
+40,000
New +$400K
HURC icon
2905
Hurco Companies Inc
HURC
$135M
$392K ﹤0.01%
13,191
-2,055
-13% -$65.5K
ICU icon
2906
SeaStar Medical
ICU
$13.7M
$392K ﹤0.01%
+156
New +$390K
OCSL icon
2907
Oaktree Specialty Lending
OCSL
$1.06B
$392K ﹤0.01%
+17,530
New +$388K
LTRX icon
2908
Lantronix
LTRX
$238M
$390K ﹤0.01%
49,705
+14,057
+39% +$107K
SSTI icon
2909
SoundThinking
SSTI
$110M
$390K ﹤0.01%
13,207
-927
-7% -$32.5K
FDX icon
2910
CALL
FedEx
FDX
$74B
$389K ﹤0.01%
1,500
-45,900
-97% -$11M
COLIW
2911
CALL
DELISTED
Colicity Inc. Warrant
COLIW
$389K ﹤0.01%
39,992
SPGS.WS
2912
CALL
DELISTED
Simon Property Group Acquisition Holdings, Inc. Warrants, each exercisable for one Class A common stock at an exercise price of $11.50 per share
SPGS.WS
$389K ﹤0.01%
39,992
MILEW
2913
CALL
DELISTED
Metromile, Inc. Warrant
MILEW
$389K ﹤0.01%
177,450
+27,450
+18% +$12.3K
WLK icon
2914
Westlake Corp
WLK
$9.25B
$388K ﹤0.01%
3,987
-5,992
-60% -$584K
SNP
2915
DELISTED
CHINA PETROLEUM & CHEMICAL CORPORATION ADS (REP 100 ORDINARY H SHARES)
SNP
$388K ﹤0.01%
+8,319
New +$402K
EVO icon
2916
Evotec
EVO
$696M
$387K ﹤0.01%
+16,272
New +$379K
TMDX icon
2917
Transmedics
TMDX
$2.64B
$386K ﹤0.01%
+20,159
New +$505K
ALRS icon
2918
Alerus Financial
ALRS
$833M
$385K ﹤0.01%
+13,148
New +$412K
GBIO
2919
DELISTED
Generation Bio
GBIO
$385K ﹤0.01%
5,447
+1,726
+46% +$301K
EQRX
2920
DELISTED
EQRx, Inc. Common Stock
EQRX
$385K ﹤0.01%
56,543
-457,394
-89% -$4.32M
RMO
2921
DELISTED
Romeo Power, Inc.
RMO
$385K ﹤0.01%
+105,528
New +$455K
OCG icon
2922
Oriental Culture Holding
OCG
$3.45M
$384K ﹤0.01%
23
-1
-4% -$14.4K
GWW icon
2923
W.W. Grainger
GWW
$66B
$382K ﹤0.01%
738
-2,851
-79% -$1.34M
ATLO icon
2924
AMES National
ATLO
$271M
$381K ﹤0.01%
15,557
-2,071
-12% -$50.1K
BCSF icon
2925
Bain Capital Specialty
BCSF
$833M
$381K ﹤0.01%
25,050
-99,925
-80% -$1.54M

Similar funds

Marshall Wace's Q4 2021 Portfolio in Review

As of Q4 2021, Marshall Wace held 4,600 positions worth $54.2B, up 125% from $24.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace deployed $28.6B of net new capital in Q4 2021, opening 1,635 new positions and adding to 1,281 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 1,140,732 shares worth $542M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Accenture, an estimated $192M trimmed.

  • Marshall Wace's largest Q4 2021 buy was State Street SPDR S&P 500 ETF Trust: 1,140,732 shares worth $542M.
  • Marshall Wace added most to Microsoft in Q4 2021, an estimated $1.08B increase.
  • Marshall Wace's biggest Q4 2021 reduction was Accenture, cutting an estimated $192M.
  • Marshall Wace fully exited Sabre in Q4 2021, selling an estimated $44.1M.
  • Marshall Wace's ten largest holdings make up 16% of its $54.2B portfolio in Q4 2021.
  • Marshall Wace opened 1,635 new positions and closed 782 in Q4 2021.
  • Marshall Wace's portfolio value rose 125% quarter-over-quarter to $54.2B.

Based on Marshall Wace's 13F filing for Q4 2021, filed 14 Feb 2022.